This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Endologix Inc (ELGX)

NASDAQ: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 153.61M 147.59M 132.26M 105.95M
Cost of Sales 41.03M 34.54M 30.20M 23.10M
Gross Operating Profit 112.58M 113.05M 102.05M 82.85M
Selling, General, and Administrative Expenses 128.28M 113.32M 93.68M 85.98M
Research & Development 26.42M 21.62M 16.20M 16.57M
Operating Income before D & A (EBITDA) -42.13M -21.89M -7.82M -19.71M
Depreciation & Amortization 10.79M 7.26M 2.55M 2.18M
Interest Income 175.00K 245.00K 50.00K 30.00K
Other Income - Net 453.00K 2.13M -5.44M -13.38M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -52.28M -26.77M -15.76M -35.24M
Interest Expense 7.48M 5.71M 321.00K 7.00K
Pre-Tax Income -59.76M -32.48M -16.08M -35.24M
Income Taxes -9.34M -62.00K -10.00K 531.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -50.42M -32.42M -16.07M -35.77M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -50.42M -32.42M -16.07M -35.77M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -50.42M -32.42M -16.07M -35.77M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-50.42M -32.42M -16.07M -35.77M
Preferred Dividends
Net Income Available To Common -50.42M -32.42M -16.07M -35.77M
Basic EPS from Continuing Ops. -0.75 -0.50 -0.26 -0.60
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.75 -0.50 -0.26 -0.60
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.75 -0.50 -0.26 -0.60
Basic Normalized Net Income/Share -0.75 -0.50 -0.26 -0.60
EPS fr Continuing Ops. -0.75 -0.50 -0.26 -0.60
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.75 -0.50 -0.26 -0.60
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.75 -0.50 -0.26 -0.60
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.75 -0.50 -0.26 -0.60
Dividends Paid per Share 0.00 0.00 0.00 0.00
ELGX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for ELGX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 4
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ELGX ANALYST REPORT

ELGX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs